Xu Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xu Zhang has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Chunping Yang
Department of Otorhinolaryngology Head and Neck Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi Province, China
7 shared publications Mengyuan Liu
Nanchang University
6 shared publicationsRui Yang
Nanchang University
6 shared publicationsDaoming Bai
Nanchang University
5 shared publicationsZhiqiang Zhang
Nanchang University
5 shared publicationsBing Guan
Department of Otolaryngology—Head and Neck Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou University, Jiangsu Province, China
4 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 92 (6) , 101919
Frailty index predicts hearing loss in middle-aged and older adults: A triangulated analysis of global, cohort, and genetic data
- 17 October 2026
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 92 (6) , 101919
Open AccessFrailty index predicts hearing loss in middle-aged and older adults: A triangulated analysis of global, cohort, and genetic data
- Open Access
- 30 June 2026
- Published by Taylor & Francis in Virulence
- Vol. 17 (1) , 2690759
Bridging environmental pollution and immune dysregulation: How microplastics disrupt gut homeostasis to promote allergic diseases
Parallel increases in microplastic (MP) pollution and allergic diseases suggest an environmental link in allergy pathogenesis. While intestinal barrier dysfunction and dysbiosis are hallmark features of allergic diseases, the mechanisms by which persistent MPs drive these processes remain unclear. This review proposes a mechanistic pathway where orally ingested MPs disrupt the intestinal barrier through physical and chemical toxicity, precipitating functional dysbiosis. Specifically, MPs suppress key short-chain fatty acid (SCFA)-producing commensals. The resulting SCFA deficit impairs the "gut-airway axis," weakening respiratory immune tolerance and increasing allergen susceptibility. We further argue for integrating gut health assessments into standardized allergy diagnostics and treatments. Despite this novel perspective, significant knowledge gaps remain regarding causality, dose-response relationships, and specific biomarkers. Addressing these challenges is critical for translating scientific findings into public health policies and clinical interventions to mitigate the rising global burden of allergic diseases.
- 30 June 2026
- Published by Taylor & Francis in Virulence
- Vol. 17 (1) , 2690759
Open AccessBridging environmental pollution and immune dysregulation: How microplastics disrupt gut homeostasis to promote allergic diseases
Parallel increases in microplastic (MP) pollution and allergic diseases suggest an environmental link in allergy pathogenesis. While intestinal barrier dysfunction and dysbiosis are hallmark features of allergic diseases, the mechanisms by which persistent MPs drive these processes remain unclear. This review proposes a mechanistic pathway where orally ingested MPs disrupt the intestinal barrier through physical and chemical toxicity, precipitating functional dysbiosis. Specifically, MPs suppress key short-chain fatty acid (SCFA)-producing commensals. The resulting SCFA deficit impairs the "gut-airway axis," weakening respiratory immune tolerance and increasing allergen susceptibility. We further argue for integrating gut health assessments into standardized allergy diagnostics and treatments. Despite this novel perspective, significant knowledge gaps remain regarding causality, dose-response relationships, and specific biomarkers. Addressing these challenges is critical for translating scientific findings into public health policies and clinical interventions to mitigate the rising global burden of allergic diseases.
- 17 June 2026
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 47 (9) , 1094-1102
The Correlation Between the Prognostic Nutritional Index and Sudden Sensorineural Hearing Loss With Comorbid Nonalcoholic Fatty Liver Disease: A Prospective Study
Objective: Sudden sensorineural hearing loss (SSNHL) is a frequent emergency in the field of otolaryngology. A comprehensive analysis of its clinical traits and risk factors is essential for clarifying its pathogenesis and creating effective prevention and treatment methods. The objective of this study was to investigate the correlation between the Prognostic Nutritional Index (PNI) and SSNHL in patients with comorbid nonalcoholic fatty liver disease (NAFLD). Methods: This prospective study enrolled 120 SSNHL patients, who were subsequently divided into an NAFLD group and a non-NAFLD group. Using propensity score matching (PSM), a comparative analysis was conducted on clinical indicators between the two patient groups, including the severity, type, prognosis of SSNHL, and PNI levels. Results: The analyses revealed that, compared with their non-NAFLD counterparts, patients with comorbid NAFLD exhibited significantly lower PNI levels, were older, had abnormal audiometric configurations, more severe hearing loss, and had a weaker prognosis. These variations are statistically remarkable. Across the various types of SSNHL patients, PNI levels progressively decreased as the disease severity progressed ( P < 0.001). However, no remarkable association was observed between PNI and the prognosis of SSNHL. Conclusion: Among individuals with SSNHL, patients with comorbid NAFLD exhibit lower PNI levels, more severe hearing loss, and a weaker prognosis than those without NAFLD. A remarkable correlation was identified between PNI levels and both the severity and type of SSNHL. No significant association was found between PNI and the prognosis of SSNHL.
- 17 June 2026
- Published by Wolters Kluwer Health in Otology & Neurotology
- Vol. 47 (9) , 1094-1102
The Correlation Between the Prognostic Nutritional Index and Sudden Sensorineural Hearing Loss With Comorbid Nonalcoholic Fatty Liver Disease: A Prospective Study
Objective: Sudden sensorineural hearing loss (SSNHL) is a frequent emergency in the field of otolaryngology. A comprehensive analysis of its clinical traits and risk factors is essential for clarifying its pathogenesis and creating effective prevention and treatment methods. The objective of this study was to investigate the correlation between the Prognostic Nutritional Index (PNI) and SSNHL in patients with comorbid nonalcoholic fatty liver disease (NAFLD). Methods: This prospective study enrolled 120 SSNHL patients, who were subsequently divided into an NAFLD group and a non-NAFLD group. Using propensity score matching (PSM), a comparative analysis was conducted on clinical indicators between the two patient groups, including the severity, type, prognosis of SSNHL, and PNI levels. Results: The analyses revealed that, compared with their non-NAFLD counterparts, patients with comorbid NAFLD exhibited significantly lower PNI levels, were older, had abnormal audiometric configurations, more severe hearing loss, and had a weaker prognosis. These variations are statistically remarkable. Across the various types of SSNHL patients, PNI levels progressively decreased as the disease severity progressed ( P < 0.001). However, no remarkable association was observed between PNI and the prognosis of SSNHL. Conclusion: Among individuals with SSNHL, patients with comorbid NAFLD exhibit lower PNI levels, more severe hearing loss, and a weaker prognosis than those without NAFLD. A remarkable correlation was identified between PNI levels and both the severity and type of SSNHL. No significant association was found between PNI and the prognosis of SSNHL.
- 13 April 2026
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1558 (1) , e70258
The Nasal Microbiome in Inflammation and Disease: Bridging Mechanisms to Therapeutics
The nasal microbiome, an integral component of the upper respiratory tract's microecological system, plays a pivotal role in inflammatory diseases such as allergic rhinitis and chronic sinusitis, which affect a substantial population and markedly reduce quality of life. A healthy nasal flora and its metabolites are crucial for maintaining immune homeostasis and mucosal barrier integrity. This review comprehensively discusses the pathological mechanisms, immune interactions, and clinical intervention strategies involving the nasal microbiota in nasal inflammation. It has been shown that dysbiosis of the nasal flora disrupts immune function and compromises the epithelial barrier, thereby initiating and exacerbating a vicious cycle of inflammation. Furthermore, the formation of bacterial biofilms and the emergence of drug resistance contribute to persistent and recurrent symptoms. Regarding treatment, while antibiotics may offer short‐term efficacy, they risk aggravating the microbial imbalance. In contrast, therapies including probiotics, novel immunomodulators, and traditional Chinese medicine demonstrate significant therapeutic potential by restoring microbial balance and modulating immune responses. This review synthesizes current research to provide new perspectives for understanding host–microbiome interactions and to guide future clinical treatments and drug development.
- 13 April 2026
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1558 (1) , e70258
The Nasal Microbiome in Inflammation and Disease: Bridging Mechanisms to Therapeutics
The nasal microbiome, an integral component of the upper respiratory tract's microecological system, plays a pivotal role in inflammatory diseases such as allergic rhinitis and chronic sinusitis, which affect a substantial population and markedly reduce quality of life. A healthy nasal flora and its metabolites are crucial for maintaining immune homeostasis and mucosal barrier integrity. This review comprehensively discusses the pathological mechanisms, immune interactions, and clinical intervention strategies involving the nasal microbiota in nasal inflammation. It has been shown that dysbiosis of the nasal flora disrupts immune function and compromises the epithelial barrier, thereby initiating and exacerbating a vicious cycle of inflammation. Furthermore, the formation of bacterial biofilms and the emergence of drug resistance contribute to persistent and recurrent symptoms. Regarding treatment, while antibiotics may offer short‐term efficacy, they risk aggravating the microbial imbalance. In contrast, therapies including probiotics, novel immunomodulators, and traditional Chinese medicine demonstrate significant therapeutic potential by restoring microbial balance and modulating immune responses. This review synthesizes current research to provide new perspectives for understanding host–microbiome interactions and to guide future clinical treatments and drug development.
- Top Cited PapersOpen Access
- 1 January 2026
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 22 (3) , 1322-1345
The Immunogenetic Landscape of Allergic Rhinitis: from Cellular Effectors to Gene Regulation and Targeted Therapies
Allergic Rhinitis (AR) is a highly prevalent type 2 inflammatory disease driven by a complex immunogenetic background. This review aims to systematically delineate the immunogenetic landscape of AR, elucidating the complete knowledge chain from macroscopic cellular interactions and microscopic molecular regulation to precision targeted therapies. The article first dissects the two core immune axes driving the pathological process of AR: one is the classic adaptive immune pathway, centered on Th2 cells, which mediates IgE production, eosinophil infiltration, and mucus hypersecretion through the secretion of cytokines such as IL-4, IL-5, and IL-13; the other is the innate immune initiation pathway, in which nasal epithelial cells act as "sentinels" by releasing "alarmins" like TSLP and IL-33, leading to the rapid activation of type 2 innate lymphoid cells (ILC2s). The review then delves into the sophisticated signaling networks that regulate these immune responses, with a particular focus on the classic IL-4/STAT6/GATA3 signaling axis and its negative regulatory mechanisms. Building on this, the article further elaborates on the genetic susceptibility architecture of AR, highlighting key risk loci identified by genome-wide association studies (GWAS), such as variants in antigen presentation genes (HLA), epithelial barrier genes (FLG), and genes related to cytokine signaling pathways. To connect genetics with the environment, this review systematically summarizes epigenetic regulatory mechanisms, including DNA methylation, histone modifications, and microRNAs (miRNAs), and discusses the long-range immunomodulatory effects of nasal and gut microbiota dysbiosis on AR via the "gut-nasal axis". Finally, from a translational medicine perspective, the article demonstrates how a profound understanding of these pathophysiological mechanisms has successfully spurred the development of highly effective targeted biologics, such as omalizumab (targeting IgE), dupilumab (targeting the IL-4Rα receptor, thus blocking IL-4/IL-13 signaling), and tezepelumab (targeting TSLP). This review integrates the latest multidimensional research advances in immunology, genetics, epigenetics, and microbiome studies of AR, providing a comprehensive theoretical framework for understanding its complex pathogenesis and for the development of future personalized treatment strategies.
- 1 January 2026
- Published by Ivyspring International Publisher in International Journal of Biological Sciences
- Vol. 22 (3) , 1322-1345
Top Cited PapersOpen AccessThe Immunogenetic Landscape of Allergic Rhinitis: from Cellular Effectors to Gene Regulation and Targeted Therapies
Allergic Rhinitis (AR) is a highly prevalent type 2 inflammatory disease driven by a complex immunogenetic background. This review aims to systematically delineate the immunogenetic landscape of AR, elucidating the complete knowledge chain from macroscopic cellular interactions and microscopic molecular regulation to precision targeted therapies. The article first dissects the two core immune axes driving the pathological process of AR: one is the classic adaptive immune pathway, centered on Th2 cells, which mediates IgE production, eosinophil infiltration, and mucus hypersecretion through the secretion of cytokines such as IL-4, IL-5, and IL-13; the other is the innate immune initiation pathway, in which nasal epithelial cells act as "sentinels" by releasing "alarmins" like TSLP and IL-33, leading to the rapid activation of type 2 innate lymphoid cells (ILC2s). The review then delves into the sophisticated signaling networks that regulate these immune responses, with a particular focus on the classic IL-4/STAT6/GATA3 signaling axis and its negative regulatory mechanisms. Building on this, the article further elaborates on the genetic susceptibility architecture of AR, highlighting key risk loci identified by genome-wide association studies (GWAS), such as variants in antigen presentation genes (HLA), epithelial barrier genes (FLG), and genes related to cytokine signaling pathways. To connect genetics with the environment, this review systematically summarizes epigenetic regulatory mechanisms, including DNA methylation, histone modifications, and microRNAs (miRNAs), and discusses the long-range immunomodulatory effects of nasal and gut microbiota dysbiosis on AR via the "gut-nasal axis". Finally, from a translational medicine perspective, the article demonstrates how a profound understanding of these pathophysiological mechanisms has successfully spurred the development of highly effective targeted biologics, such as omalizumab (targeting IgE), dupilumab (targeting the IL-4Rα receptor, thus blocking IL-4/IL-13 signaling), and tezepelumab (targeting TSLP). This review integrates the latest multidimensional research advances in immunology, genetics, epigenetics, and microbiome studies of AR, providing a comprehensive theoretical framework for understanding its complex pathogenesis and for the development of future personalized treatment strategies.
- 8 December 2025
- Published by Wiley in Immunology
- Vol. 177 (4) , 749-751
Microplastics in Allergic Rhinitis: Multimechanistic Drivers of Barrier Disruption and Immune Dysregulation
- 8 December 2025
- Published by Wiley in Immunology
- Vol. 177 (4) , 749-751
Microplastics in Allergic Rhinitis: Multimechanistic Drivers of Barrier Disruption and Immune Dysregulation
- Open Access
- 17 October 2025
- Published by Wiley
M2 Macrophage Polarization and Its Role in Nasal Diseases: Signaling Pathways and Therapeutic Implications
Macrophages—particularly alternatively activated M2 phenotypes—bridge the resolution of inflammation and tissue repair in nasal mucosal disease and allergic airway disorders. Recent advances have delineated a complex signaling architecture governing M2 polarization, including JAK/STAT (STAT6 and STAT3), PI3K/Akt/mTOR, MAPK, Notch, NF-κB, and TGF-β/Smad pathways, along with epigenetic and metabolic circuits. In chronic rhinosinusitis with nasal polyps (CRSwNP), M2 macrophages interact with epithelial and type 2 lymphoid compartments, exhibit defective bactericidal/autophagic functions, and contribute to tissue remodeling through coagulation and damage-associated signals. In allergic rhinitis and asthma, M2 programs orchestrate Th2 amplification, eosinophil recruitment, and airway remodeling, yet can also mediate resolution in appropriate contexts. We synthesize mechanistic insights and disease-specific roles, highlight therapeutic strategies that modulate M2 states, and outline outstanding gaps toward precise macrophage reprogramming in rhinologic disease.
- 17 October 2025
- Published by Wiley
Open AccessM2 Macrophage Polarization and Its Role in Nasal Diseases: Signaling Pathways and Therapeutic Implications
Macrophages—particularly alternatively activated M2 phenotypes—bridge the resolution of inflammation and tissue repair in nasal mucosal disease and allergic airway disorders. Recent advances have delineated a complex signaling architecture governing M2 polarization, including JAK/STAT (STAT6 and STAT3), PI3K/Akt/mTOR, MAPK, Notch, NF-κB, and TGF-β/Smad pathways, along with epigenetic and metabolic circuits. In chronic rhinosinusitis with nasal polyps (CRSwNP), M2 macrophages interact with epithelial and type 2 lymphoid compartments, exhibit defective bactericidal/autophagic functions, and contribute to tissue remodeling through coagulation and damage-associated signals. In allergic rhinitis and asthma, M2 programs orchestrate Th2 amplification, eosinophil recruitment, and airway remodeling, yet can also mediate resolution in appropriate contexts. We synthesize mechanistic insights and disease-specific roles, highlight therapeutic strategies that modulate M2 states, and outline outstanding gaps toward precise macrophage reprogramming in rhinologic disease.
- 1 October 2025
- Published by Elsevier in Environmental Research
- Vol. 286 (Pt 3) , 123007
Airway exposure to microplastics: Potential mechanisms from epithelial barrier damage to the development of allergic rhinitis
- 1 October 2025
- Published by Elsevier in Environmental Research
- Vol. 286 (Pt 3) , 123007
Airway exposure to microplastics: Potential mechanisms from epithelial barrier damage to the development of allergic rhinitis
- 13 September 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (1) , 100-106
Inflammatory Cytokines and the Risk of Sensorineural Hearing Loss: A Mendelian Randomization Study
- 13 September 2025
- Published by Springer Nature in Indian Journal of Otolaryngology and Head & Neck Surgery
- Vol. 78 (1) , 100-106
Inflammatory Cytokines and the Risk of Sensorineural Hearing Loss: A Mendelian Randomization Study